A contract manufacturing organization, also known as a contract manufacturing and development organization, is an organization that serves pharmaceutical companies on a contract basis to offer comprehensive services from invention through commercialization to provide pharmaceuticals for healthcare. The primary function of these organizations is to provide the pharmaceutical and biotechnology industries with products that are designed, developed and manufactured under contract. Contract manufacturers usually build their business in close association with the pharmaceutical and bio-tech groups. As a result of this close relationship, these organizations can offer the same quality and quantity of products that would be available through the licensed facility. There are a number of advantages to contract manufacturing from a contract manufacturer.
Market Dynamics:
Increasing investment in R&D of drugs is expected to propel growth of the global healthcare CMO market over the forecast period. For instance, in September 2021, Aragen Life Sciences announced its plans to invest in expanding infrastructure in Hyderabad and Bengaluru (India) for drug discovery, and building a new facility in the U.S to manufacture biologics. Similarly, in August 2021, Curia announced plans to expand its commercial manufacturing capacity at its Rensselaer, NY facility.
Key features of the study:
- This report provides in-depth analysis of the global healthcare CMO market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global healthcare CMO market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Accellent, Inc., Boehringer Ingelheim GmbH, Catalent Pharma Solutions, Inc., DSM, Fareva, Greatbatch, Inc., Lonza Group, Patheon, Inc. (Thermo Fisher Scientific Inc.), Piramal Healthcare, Binex, Cytovance Biologics, Emergent BioSolutions Inc., MilliporeSigma, Symbiosis Pharmaceutical Services, Albany Molecular Research Inc., Samsung Biologics, and Symmetry Medical, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global healthcare CMO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global healthcare CMO market
Detailed Segmentation:
- Global Healthcare CMO Market , By Service:
- Pharmaceutical Contract Manufacturing Services
- Medical Device Contract Manufacturing Services
- Global Healthcare CMO Market, By Region:
- North America
- North America Healthcare CMO Market , By Service:
- Pharmaceutical Contract Manufacturing Services
- Medical Device Contract Manufacturing Services
- By Country
- Latin America
- Latin America Healthcare CMO Market , By Service:
- Pharmaceutical Contract Manufacturing Services
- Medical Device Contract Manufacturing Services
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Europe Healthcare CMO Market , By Service:
- Pharmaceutical Contract Manufacturing Services
- Medical Device Contract Manufacturing Services
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Asia Pacific Healthcare CMO Market , By Service:
- Pharmaceutical Contract Manufacturing Services
- Medical Device Contract Manufacturing Services
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Middle East Healthcare CMO Market , By Service:
- Pharmaceutical Contract Manufacturing Services
- Medical Device Contract Manufacturing Services
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- Africa Healthcare CMO Market , By Service:
- Pharmaceutical Contract Manufacturing Services
- Medical Device Contract Manufacturing Services
- By Country
- North Africa
- Central Africa
- South Africa
- Company Profiles
-
- Accellent, Inc.*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategy
- Boehringer Ingelheim GmbH
- Catalent Pharma Solutions, Inc.
- DSM
- Fareva
- Greatbatch, Inc.
- Lonza Group
- Patheon, Inc. (Thermo Fisher Scientific Inc.)
- Piramal Healthcare
- Binex
- Cytovance Biologics
- Emergent BioSolutions Inc.
- MilliporeSigma
- Symbiosis Pharmaceutical Services
- Albany Molecular Research Inc.
- Samsung Biologics
“*” marked represents similar segmentation in other categories in the respective section.
